About Choice ClinOps
Embedded executive clinical operations leadership, governance, and execution for global oncology, rare disease, and gene therapy sponsors.
The Sponsor-Side Command Center
Embedded leadership that strengthens sponsor control
Choice ClinOps provides fractional and embedded executive clinical operations leadership, governance, and execution for high-stakes global oncology, rare disease, and gene therapy clinical trials.
Differentiation
Not a CRO. Not staffing. Not Generic consulting.
Executive-level clinical operations judgment, governance discipline, and execution authority without full-time overhead. Leadership and execution by senior clinical trial operations experts with hands-on execution experience.
Why Top Sponsors Trust Choice ClinOps
Fractional executive-grade leadership
High-risk therapeutic specialization - Built for Complexity
High-risk therapeutic specialization - Built for Complexity
Access senior sponsor-side clinical operations leadership without the lag, rigidity, or full-time cost of a permanent hire. Embedded leadership matched to sponsor needs.
High-risk therapeutic specialization - Built for Complexity
High-risk therapeutic specialization - Built for Complexity
High-risk therapeutic specialization - Built for Complexity
Oncology, rare disease, and gene therapy programs require operational judgment that generalist models often miss.
Execution, not advice alone
High-risk therapeutic specialization - Built for Complexity
Execution, not advice alone
Choice ClinOps does not stop at recommendations. We drive oversight, accountability, alignment, and follow-through.
Continuity Under Pressure
Financial discipline with human-centered execution
Execution, not advice alone
Designed for rescue, harmonization, and global execution.
Financial discipline with human-centered execution
Financial discipline with human-centered execution
Financial discipline with human-centered execution
We focus on budget and quality protection, timeline and data integrity, site trust, patient and caregiver burden awareness and alleviation, and practical operational realism.
What Choice ClinOps Does
Strengthened continuity, governance, execution, and control across high-stakes global trials.
Choice ClinOps partners with global small and mid-size sponsors of oncology, rare disease, and gene therapy clinical trials to strengthen continuity, governance, execution, and control during growth, drift, and transition.
Founder Section
Led by Leila Cupersmith
Leila Cupersmith leads a team of fractional and embedded senior and executive-level clinical trial operations specialists to partner with global small- and mid-size clinical trial sponsors to strengthen control, rescue at-risk studies, and improve CRO, vendor, and site governance.
Team Section
Founder-Led. Senior-Team Executed.
Choice ClinOps is supported by senior and executive-level global clinical trial operations leaders across leadership, governance, oversight, rescue, harmonization, and site management.
Speaking / Publications
Speaking and Published Insights
Leila Cupersmith speaks globally on clinical operations and publishes executive insights with Clinical Leader.
Book an Executive Diagnostic
When the science is valuable, execution cannot be left to chance.
Each diagnostic is designed to identify the highest-priority operational risks, define near-term action paths, and give leadership a sharper decision framework.
Receive weekly ClinOps tips, strategies, and insights.
Copyright © 2025 Choice ClinOps | Oncology, Rare Disease, and Gene Therapy Trial Execution - All Rights Reserved.